The titration schedule is a maximum framework, not a mandatory escalation
The industry must now address critical challenges, including pricing negotiations, payer coverage limitations, supply constraints and the preservation of muscle mass during weight loss, with solutions emerging through novel mechanisms targeting amylin, cannabinoid receptors and activin pathways. 1 Sales Projections Far Outpace Other Drugs on Clarivates 2026 Watch List An FDA decision on orforglipron is expected by March 2026, with Clarivate projecting retatrutide will be ready for launch in 2028
They are caused by the physical act of injection plus local immune response to the injected substance
BOLD fMRI acquisition and methodology is described in detail below
Among the main differences between liraglutide and semaglutide lies in their dosing schedules and specific effects on weight loss, with liraglutide requiring daily administration and semaglutide taken once a week
Stimulating the pituitary gland to usher in a wave of growth hormone